One of the nation’s top experts on how disease arises in humans has been appointed the new president of the Salk Institute in La Jolla, which is undergoing a historic expansion that’s meant to help scientists demystify everything from cancer to dementia.
Joyce told the Union-Tribune that the Salk has scrapped plans to try to raise $500 million over a five-year period and will now seek $750 million over seven years, concluding the campaign in 2028. Joyce subsequently moved to Scripps Research in La Jolla, where he conducted research and served as dean of the faculty. Then he spent seven years overseeing drug discovery at the Genomics Institute of the Novartis Research Foundation in La Jolla. He returned to the Salk in 2017. He’ll assume the presidency in April.
Sciences are increasingly targeting RNA itself in ways that might help in the battle against cancer, a family of diseases that killed more than 600,000 people in the U.S. in 2020.Three female scientists filed lawsuits, alleging that they were subjected to gender discrimination. Nobel laureate Elizabeth Blackburn, who was then president of the Salk, took thestep of publicly raising questions about the quality and quantity of the work done by two of the women.
Yay science. :) — “Science is a blast.” ‘Gerald Joyce is Salk Institute’s new president. He sees his new role as encouraging researchers to explore “the next opportunities in science.”’ ‘I learned to be a scientist at Salk. There is a sense of adventure and scientific rigor,…